| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 333.14B | 334.43B | 346.36B | 335.05B | 287.63B | 256.00B |
| Gross Profit | 56.88B | 57.08B | 56.88B | 45.54B | 46.20B | 46.64B |
| EBITDA | 22.02B | 27.18B | 27.08B | 21.17B | 16.19B | 20.55B |
| Net Income | 9.18B | 11.60B | 12.36B | 7.78B | 4.01B | 10.12B |
Balance Sheet | ||||||
| Total Assets | 258.35B | 258.77B | 265.85B | 251.59B | 235.38B | 217.70B |
| Cash, Cash Equivalents and Short-Term Investments | 7.72B | 8.11B | 8.14B | 6.22B | 9.17B | 11.16B |
| Total Debt | 51.68B | 53.95B | 58.74B | 63.26B | 56.14B | 45.77B |
| Total Liabilities | 118.45B | 120.14B | 132.59B | 135.23B | 126.28B | 114.62B |
| Stockholders Equity | 136.24B | 134.98B | 129.61B | 113.00B | 105.70B | 99.61B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 8.49B | 12.64B | -13.05B | -10.03B | 3.01B |
| Operating Cash Flow | 0.00 | 20.27B | 23.75B | -2.93B | 1.33B | 13.77B |
| Investing Cash Flow | 0.00 | -11.38B | -12.40B | -6.16B | -11.73B | -26.38B |
| Financing Cash Flow | 0.00 | -10.06B | -9.44B | 6.14B | 8.40B | 13.80B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥60.95B | 4.62 | ― | 2.44% | 5.74% | 76.28% | |
76 Outperform | ¥224.60B | 9.63 | 7.56% | 2.84% | 2.63% | -7.81% | |
71 Outperform | ¥105.59B | 7.71 | ― | 3.80% | -2.01% | -29.88% | |
71 Outperform | ¥67.81B | 13.32 | ― | 3.98% | 1.21% | -14.59% | |
63 Neutral | ¥60.74B | 22.47 | ― | 0.34% | 4.70% | -2.58% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
53 Neutral | ¥96.58B | 7.70 | ― | 3.59% | 4.55% | 79.33% |